Immunoprecise Antibodies Ltd
XTSX:IPA
Dividends
Dividend Yield
Immunoprecise Antibodies Ltd
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Immunoprecise Antibodies Ltd
IPA have
decreased
by 0%.
Payout Ratio
Immunoprecise Antibodies Ltd
| Current Payout | |
| Min Payout | |
| Max Payout | |
| Average Payout | |
| Median Payout |
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for
IPA is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Peers Comparison
Shareholder Yield
Price Appreciation
IPA Price
Immunoprecise Antibodies Ltd
| Average Annual Return |
N/A
|
| Standard Deviation of Annual Returns |
N/A
|
| Max Drawdown | -72% |
| Market Capitalization | 161.4m CAD |
| Shares Outstanding | 24 836 700 |
| Percentage of Shares Shorted | 0.29% |
IPA Return Decomposition
Main factors of price return
Stock Splits
IPA's latest stock split occurred on Nov 23, 2020
The company executed a 1-for-5 stock split, meaning that for every 5 shares held, investors received 1 new share.
Before the split, IPA traded at 8.35 per share. Afterward, the share price was about 9.81.
The adjusted shares began trading on Nov 23, 2020. This was IPA's 3rd stock split, following the previous one in Sep 2, 2016.